Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-like protein 7A (ACTL7A) is a testis-specific actin-related protein essential for normal sperm head morphology, acrosome formation, and acrosome attachment. It is a structural component of the cytoskeleton and localizes to the acrosome and nucleus of developing male germ cells, playing a critical role in spermatogenesis, fertilization, and early embryonic development. Mutations in ACTL7A are associated with defects in acrosome integrity, impaired fertilization, and male infertility. Beyond its structural roles, ACTL7A and its homolog ACTL7B contribute to the regulation of chromatin structure and gene expression during spermiogenesis, linking nuclear architecture to sperm function and fertility. ACTL7A is not currently recognized as a therapeutic target, and there are no drugs known to modulate its activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-like protein 7A (ACTL7A).